MRSA-specific antibiotics might be overprescribed for DFIs | Commentary: FDA should scrutinize Section 361 human cell and tissue products | Wound care center opens in Rio Grande Valley
September 14, 2016
CONNECT WITH ADVTIS  Facebook
Advanced Tissue SmartBrief
Your resource for current wound care information
SIGN UP ⋅   FORWARD
Wound Care Update
MRSA-specific antibiotics might be overprescribed for DFIs
Fifteen percent of 318 diabetic foot infections studied involved methicillin-resistant Staphylococcus aureus, but 86% of the patients in the study were prescribed antibiotics to treat MRSA, according to a study in PLOS ONE.
Dermatology News (9/13) 
LinkedIn Twitter Facebook Google+ Email
Commentary: FDA should scrutinize Section 361 human cell and tissue products
Section 361 human cell and tissue products do not have to undergo the FDA premarket approval process but can claim to be equally or more effective than FDA-approved wound therapies, potentially affecting clinical decisions that could lead to lower-limb amputation, writes Jack Richmond, interim president and CEO at the Amputee Coalition. "The Amputee Coalition believes the FDA must prevent unsubstantiated and misleading promotional claims made by manufacturers of Section 361 HCT/Ps, and expand adverse event reporting for these products to the same level required for drugs and medical devices, to ensure their efficacy and safety," Richmond writes.
The Hill (9/9) 
LinkedIn Twitter Facebook Google+ Email
Wound care center opens in Rio Grande Valley
Edinburg Regional Medical Center in Edinburg, Texas, opened a wound care center that offers hyperbaric oxygen, among other therapies.
KVEO-TV (Brownsville, Texas) (9/9),  KGBT-TV (Harlingen, Texas) (9/9) 
LinkedIn Twitter Facebook Google+ Email
Research, Technology & Innovation
Experimental device accelerates hemostasis in skin lesions
A hemostatic device based on self-assembling peptide technology was found to be safe and stanched bleeding in skin lesions faster than standard care in a clinical study, according to manufacturer Arch Therapeutics.
Modern Medicine/Cosmetic Surgery Times (9/8) 
LinkedIn Twitter Facebook Google+ Email
Other News
Health Policy & Regulation
CMS offers doctors 4 MACRA compliance options
Physicians will have four Quality Payment Program options next year under the Medicare Access and CHIP Reauthorization Act, acting CMS Administrator Andy Slavitt wrote in a blog post. Physicians can choose to test the program, participate for part of the year or for the full year, or participate in an alternative payment model such as an accountable care organization.
MedPage Today (free registration) (9/8),  Modern Healthcare (tiered subscription model) (9/8) 
LinkedIn Twitter Facebook Google+ Email
Surgeons protest Medicare coding proposal
The American Medical Association, the American College of Surgeons, and societies representing orthopedic and neurological surgeons are among the organizations objecting to a CMS proposal that surgeons use new billing codes to document their work in 10-minute segments during 10-day and 90-day global surgical packages. Surgeons would have to document the number and level of pre- and postoperative visits in every global package using "G" codes that describe 10 minutes of care, which surgeons say does not reflect real-world conditions.
Medscape (free registration) (9/8) 
LinkedIn Twitter Facebook Google+ Email
Learn more about ADVTIS:
Meet Our People | Placing an Order
Why Use Advanced Tissue | Home
  
  
Excellent firms don't believe in excellence -- only in constant improvement and constant change.
Tom Peters,
writer and management consultant
LinkedIn Twitter Facebook Google+ Email
  
  
About Advanced Tissue
Advanced Tissue is a leading wound care supply company offering a comprehensive line of wound care products from virtually all manufacturers. We understand the many obstacles associated with effective wound treatment and use this insight to provide the efficient delivery of dressings to enable enhanced compliance and improved patient outcomes.
 
Contact Advanced Tissue
7003 Valley Ranch Drive
Little Rock, Arkansas 72223
1-866-217-9900
www.AdvancedTissue.com/
info@advtis.com
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information